2-mercaptomethyl-3-guanidinoethylthiopropionic acid has been researched along with Blood Clot in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishii, H; Muto, Y; Sato, E; Suzuki, K | 1 |
| Hendriks, D; Leurs, J | 1 |
1 review(s) available for 2-mercaptomethyl-3-guanidinoethylthiopropionic acid and Blood Clot
| Article | Year |
|---|---|
Carboxypeptidase U (TAFIa): a metallocarboxypeptidase with a distinct role in haemostasis and a possible risk factor for thrombotic disease.
Topics: 3-Mercaptopropionic Acid; Animals; Blood Platelets; Carboxypeptidase B2; Enzyme Stability; Fibrinolysin; Hemostasis; Humans; Liver; Mice; Mice, Knockout; Polymorphism, Genetic; Protein Denaturation; Risk Factors; Succinates; Thrombin; Thrombosis | 2005 |
1 other study(ies) available for 2-mercaptomethyl-3-guanidinoethylthiopropionic acid and Blood Clot
| Article | Year |
|---|---|
Carboxypeptidase B inhibitors reduce tissue factor-induced renal microthrombi in rats.
Topics: 3-Mercaptopropionic Acid; Animals; Carboxypeptidase B; Carboxypeptidases; Dose-Response Relationship, Drug; Fibrin; Fibrinolysis; Kidney; Kidney Glomerulus; Male; Protease Inhibitors; Rats; Rats, Wistar; Thromboplastin; Thrombosis | 2003 |